Meyka AI API is live for developers.Start building.
Advertisement
Genetron Holdings Limited

Genetron Holdings Limited (GTH) Stock Overview

Explore Genetron Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

GTH●NASDAQ
HealthcareMedical - Diagnostics & Research
$4.03
$0.005(0.12%)
U.S. Market opens in 56h 3m
Advertisement

Genetron Holdings Limited (GTH)

Meyka AI Score

Z

Key Financials

Market Cap127.3M
P/E Ratio-0.95
EPS (TTM)$-3.62
ROE-1.01%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

GTH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Genetron Holdings Limited (GTH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.95 and a market capitalization of 127.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.12%
3-Month Change
6.20%
6-Month Change
15.33%
Year-to-Date (YTD) Change
9.08%
1-Year Change
42.73%
3-Year Change
-93.92%
5-Year Change
-91.61%
All-Time (Max) Change
-91.61%

Contact Information

https://www.genetronhealth.com
86 10 5090 7500
Building 11, Beijing, NaN, 102206

Company Facts

9,930 Employees
IPO DateJun 15, 2020
CountryCN

Frequently Asked Questions